Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Turn around

<< Previous

Bullboard Posts

Next >>

Comment by Charly50on May 31, 2021 6:44pm

173 Views

Post# 33299148

RE:RE:RE:RE:RE:RE:RE:Turn around

and let us not forget either:
June 5, 2021 American Transplant Congress Bachul PJ. Islet Allotransplantation into the Pre-Vascularized Sernova Cell PouchTM Device - Preliminary Results of the Phase I/II Prospective, Open-Label, Single-Arm Study at University of Chicago

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec